Bessemer Group Inc. Sells 3,272 Shares of Ceridian HCM Holding Inc. (NYSE:CDAY)

Bessemer Group Inc. trimmed its holdings in shares of Ceridian HCM Holding Inc. (NYSE:CDAYFree Report) by 11.6% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 25,022 shares of the company’s stock after selling 3,272 shares during the quarter. Bessemer Group Inc.’s holdings in Ceridian HCM were worth $1,833,000 as of its most recent filing with the SEC.

A number of other large investors have also bought and sold shares of the business. Belpointe Asset Management LLC bought a new position in shares of Ceridian HCM during the 4th quarter worth approximately $35,000. Advisors Asset Management Inc. bought a new position in shares of Ceridian HCM in the first quarter valued at $41,000. Freedom Wealth Alliance LLC bought a new position in shares of Ceridian HCM in the fourth quarter valued at $49,000. Quadrant Capital Group LLC grew its stake in shares of Ceridian HCM by 40.7% in the fourth quarter. Quadrant Capital Group LLC now owns 781 shares of the company’s stock valued at $50,000 after buying an additional 226 shares in the last quarter. Finally, Parallel Advisors LLC grew its stake in shares of Ceridian HCM by 55.6% in the fourth quarter. Parallel Advisors LLC now owns 896 shares of the company’s stock valued at $57,000 after buying an additional 320 shares in the last quarter.

Ceridian HCM Price Performance

Ceridian HCM stock opened at $69.86 on Monday. The stock’s 50 day moving average is $68.67 and its 200 day moving average is $68.18. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.10 and a quick ratio of 1.10. The firm has a market cap of $10.74 billion, a P/E ratio of -776.14, a P/E/G ratio of 4.51 and a beta of 1.44. Ceridian HCM Holding Inc. has a one year low of $51.52 and a one year high of $79.66.

Insider Buying and Selling

In related news, insider Stephen H. Holdridge sold 4,863 shares of Ceridian HCM stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $65.77, for a total value of $319,839.51. Following the transaction, the insider now directly owns 67,756 shares of the company’s stock, valued at $4,456,312.12. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other Ceridian HCM news, insider Stephen H. Holdridge sold 4,863 shares of the business’s stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $65.77, for a total value of $319,839.51. Following the transaction, the insider now directly owns 67,756 shares of the company’s stock, valued at $4,456,312.12. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP William Everett Mcdonald sold 373 shares of the business’s stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $71.42, for a total value of $26,639.66. Following the completion of the transaction, the executive vice president now directly owns 48,511 shares in the company, valued at $3,464,655.62. The disclosure for this sale can be found here. Insiders have sold a total of 39,680 shares of company stock valued at $2,665,333 over the last ninety days. 4.50% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several equities analysts recently weighed in on CDAY shares. Credit Suisse Group decreased their target price on shares of Ceridian HCM from $105.00 to $83.00 in a research note on Thursday, May 4th. Barclays raised their price target on Ceridian HCM from $73.00 to $74.00 and gave the company an “equal weight” rating in a report on Thursday, August 3rd. Wells Fargo & Company cut their price target on Ceridian HCM from $75.00 to $65.00 in a report on Thursday, May 4th. TD Cowen downgraded Ceridian HCM from an “outperform” rating to a “market perform” rating and raised their price target for the company from $69.00 to $71.00 in a report on Thursday, July 13th. Finally, DA Davidson cut their price target on Ceridian HCM from $86.00 to $77.00 in a report on Thursday, May 4th. Six analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $79.07.

Check Out Our Latest Research Report on CDAY

About Ceridian HCM

(Free Report)

Ceridian HCM Holding Inc, together with its subsidiaries, operates as a human capital management (HCM) software company in the United States, Canada, and internationally. It offers Dayforce, a cloud HCM platform that provides human resources, payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud HR and payroll solution for the small business market.

Recommended Stories

Institutional Ownership by Quarter for Ceridian HCM (NYSE:CDAY)

Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.